Less Mortality with GLP-1 Agonists in Rheumatic Patients A recent study in PLOS ONE found that treating type 2 diabetes with GLP-1-RAs lowered the risk of mortality and cardiovascular events in patients with IMIDs and type 2 diabetes. https://t.co/MzCG7WvrDS https://t.co/0RPIfOO0s7